The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

Rhys Evans has been cycle touring with Type 1 diabetes for many years, but limited the distance. Following a tour across ...

Automated insulin delivery systems are safe, effective, and well-received by older adults with type 1 diabetes, challenging ...

New research has examined how accurate continuous glucose monitors (CGM) are in comparison to capillary blood glucose ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...

An early-morning rise in blood sugar is common in people with diabetes. Find out more about why it happens and how to prevent ...

According to 2021 data from the American Diabetes Association, 2 million Americans have type 1 diabetes—304,000 of which are ...

Senseonics (NYSE:SENS) shares ticked up after hours today on fourth-quarter results that came in ahead of the consensus ...

Senseonics Holdings, Inc. ( NYSE: SENS) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Jeremy Feffer - Investor Relations, LifeSci Advisors Tim Goodnow - President and Chief Executive ...

Continuous Glucose Monitoring market poised for significant growth, driven by advancements in diabetes management and rising global prevalence.

His family criticised his trial as a "farce" and has demanded he be released having completed his sentence. Soueif, 68, has been on hunger strike for 152 days in protest against the detention, and has ...

reported that its next-generation automated insulin delivery algorithm, Control-IQ+ technology (Control-IQ+), is cleared by the U.S. FDA for use by people with type 2 diabetes (T2D) ages 18 and older.